The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation

BACKGROUND: Optimal parathyroid hormone (PTH) control during non-dialysis chronic kidney disease (ND-CKD) might decrease the subsequent risk of parathyroid hyperplasia and uncontrolled secondary hyperparathyroidism (SHPT) on dialysis. However, the evidence for recommending PTH targets and therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabibzadeh, Nahid, Karaboyas, Angelo, Robinson, Bruce M, Csomor, Philipp A, Spiegel, David M, Evenepoel, Pieter, Jacobson, Stefan H, Ureña-Torres, Pablo-Antonio, Fukagawa, Masafumi, Al Salmi, Issa, Liang, Xinling, Pisoni, Ronald L, Young, Eric W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771977/
https://www.ncbi.nlm.nih.gov/pubmed/33068419
http://dx.doi.org/10.1093/ndt/gfaa195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771977/
https://www.ncbi.nlm.nih.gov/pubmed/33068419
http://dx.doi.org/10.1093/ndt/gfaa195

Ejemplares similares